Contact Supplier

China’s top API & intermediate manufacturer, delivering advanced CMO/CDMO solutions to 60+ countries, empowering global health progress

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

5 Drugs in Development

5 Drugs in Development

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

1PROSPECTS

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Regulatory FDF Prices

MARKET PLACE

API

FDF

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 1844849-10-0, Mevrometostat, S4l4mm20b6, Pf06821497, 1(2h)-isoquinolinone, 5,8-dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((r)-methoxy-3-oxetanylmethyl)-, 1(2h)-isoquinolinone, 5,8-dichloro-2-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-3,4-dihydro-7-[(r)-methoxy-3-oxetanylmethyl]-

Molecular Formula

C₂₂H₂₄Cl₂N₂O₅

Molecular Weight

467.3 g/mol

InChI Key

RXCVUHMIWHRLDF-HXUWFJFHSA-N

FDA UNII

S4L4MM20B6

zeste homolog 2 inhibitor

1 2D Structure

Mevrometostat

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-7-[(R)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1-one

2.1.2 InChI

InChI=1S/C22H24Cl2N2O5/c1-11-6-17(29-2)15(21(27)25-11)8-26-5-4-13-16(23)7-14(19(24)18(13)22(26)28)20(30-3)12-9-31-10-12/h6-7,12,20H,4-5,8-10H2,1-3H3,(H,25,27)/t20-/m1/s1

2.1.3 InChI Key

RXCVUHMIWHRLDF-HXUWFJFHSA-N

2.2 Other Identifiers

2.2.1 UNII

S4L4MM20B6

2.3 Synonyms

2.3.1 MeSH Synonyms

1. Pf06821497

2.3.2 Depositor-Supplied Synonyms

1. 1844849-10-0

2. Mevrometostat

3. S4l4mm20b6

4. Pf06821497

5. 1(2h)-isoquinolinone, 5,8-dichloro-2-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-3,4-dihydro-7-((r)-methoxy-3-oxetanylmethyl)-

6. 1(2h)-isoquinolinone, 5,8-dichloro-2-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-3,4-dihydro-7-[(r)-methoxy-3-oxetanylmethyl]-

7. 5,8-dichloro-2-((4-methoxy-6-methyl-2-oxo-1h-pyridin-3-yl)methyl)-7-((r)-methoxy(oxetan-3-yl)methyl)-3,4-dihydroisoquinolin-1-one

8. 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1h-pyridin-3-yl)methyl]-7-[(r)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1-one

9. Pf 06821497

10. Refchem:172264

11. Ezh2 Inhibitor Pf-06821497

12. 5,8-dichloro-7-((r)-methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1,2,3,4-tetrahydroisoquinolin-1-one

13. Unii-s4l4mm20b6

14. (r)-5,8-dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2h)-one

15. Chembl4080228

16. 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(r)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoquinolin-1(2h)-one

17. Mevrometostat [inn]

18. Mevrometostat [who-dd]

19. Mevrometostat (jan/usan)

20. Mevrometostat [usan]

21. Orb1963604

22. Schembl17330426

23. Schembl29406728

24. Gtpl10516

25. Bdbm50246967

26. Ex-a11760

27. Nsc800019

28. Akos040734437

29. Db14799

30. Hy-101571a

31. Nsc-800019

32. Compound 23a [pmid: 29211475]

33. Ncgc00510267-02

34. Da-76781

35. Ts-07857

36. Cs-0092626

37. D12845

38. H68040

39. P200097

40. Q29209799

41. 5,8-dichloro-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-7-[(r)-methoxy(oxetan-3-yl)methyl]-3,4-dihydroisoqinolin-1(2h)-one

42. 5,8-dichloro-7-[(r)-methoxy(oxetan-3-yl)methyl]-2-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3,4-dihydroisoquinolin-1(2h)-one

43. Cjd

2.4 Create Date

2016-02-23

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₄Cl₂N₂O₅
Molecular Weight	467.3 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	6
Exact Mass	Da
Monoisotopic Mass	Da
Topological Polar Surface Area	77.1
Heavy Atom Count	31
Formal Charge	0
Complexity	797
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Find Mevrometostat manufacturers, exporters & distributors on PharmaCompass

Mevrometostat

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

DEVELOPMENTS

5 Drugs in Development

ACTIVE PHARMA INGREDIENTS

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

FINISHED DOSAGE FORMULATIONS

1PROSPECTS

5DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

GLOBAL SALES INFORMATION

MARKET PLACE

DIGITAL CONTENT

What are you looking for?